Children with rare diseases
    deserve therapeutic answers

    Discover
    ORPHELIA Pharma

    Development of essential
    medicines in the field of rare
    pediatric diseases.
    Read more

    Discover
    Products & Projects

    Focus on severe epileptic
    childhood syndromes and refractory
    and relapsed pediatric cancers.

    Kigabeq
    Kizfizo / Kimozo

    Latest news

    29 November 2023

    Orphelia Pharma secures US patent covering KIZFIZO®, first drinkable formulation of temozolomide

    Read More >
    28 November 2023

    ORPHELIA Pharma to support the European paediatric Soft Tissue Sarcoma Study Group winter meeting.

    Read More >
    2 November 2023

    Medicines for Europe : 5th Value Added Medicines Conference, 7th November 2023, Brussels

    Read More >